Always Remember - Buy The Dip

Sentiment Analysis For ETRM

The news is currently generally neutral for ETRM.

Based on TextBlob analysis of Yahoo! Finance news summaries for ETRM on 2015-03-03.

Yahoo! Finance News for ETRM

Despite the CDC's Best Efforts, This Disease Just Hit Record Levels
Source Flickr user Next TwentyEight. Although cancer and heart disease may garner a significant portion of researchers' attention, obesity is a growing problem . According to estimates from the Centers for Disease

Newly Approved Weight Loss Method Works by Tricking Your Brain
You can lose weight through plenty of methods. Dieting. Exercising. Taking weight loss drugs. Undergoing gastric bypass surgery. The newest way, though, just might be the coolest and most revolutionary way of all. Source

Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: Jan. 11-17, 2015
Welcome to the latest installment of community stock picks and overview of the most-read stories of the week. We're taking a look at stocks chosen by members of the Nasdaq.com community from January 11 - 17. Bullish Stocks: Heres What You Said: Expeditors International of Washington, Inc. ( EXPD ): Solid

Forget Pills! Could This Device Put an End to Obesity in America?
Source Behavorial Risk Factor Surveillance Systems, Centers for Disease Control and Prevention. Obesity might be sometimes overlooked as a disease that needs immediate attention, but the reality is it's a serious condition that

EnteroMedics : FDA Oks VBLOC Vagal Blocking Therapy To Treat Obesity; Stock Up
EnteroMedics : FDA Oks VBLOC Vagal Blocking Therapy To Treat Obesity; Stock Up

Walgreens Investors' Final Nod for Alliance Boots Takeover - Analyst Blog
Shareholders of suburban Chicago based Walgreen Co. ( WAG ), commonly known as Walgreens, has finally approved its acquisition of the remaining 55% of its European counterpart Alliance Boots GmbH, with the subsequent reorganization of the company into a

RTI Surgical Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
On Dec 30, 2014, Zacks Investment Research upgraded RTI Surgical Inc. ( RTIX ) to a Zacks Rank #1 (Strong Buy).Why the Upgrade? Impressive third quarter results, positive guidance revision, new product launches and an innovative product pipeline were

Cepheid's (CPHD) Xpert HIV Test Wins CE-IVD Mark in Europe - Analyst Blog
In an attempt to strengthen its foothold in the virology market, molecular diagnostics corporation Cepheid ( CPHD ), together with the not for profit organization Foundation for Innovative New Diagnostics (FIND), has reported the receipt of CE IVD status

Intuitive Surgical's da Vinci System Strong, Cost Woes Linger - Analyst Blog
On Dec 18, we issued an updated research report on Intuitive Surgical, Inc. ( ISRG ). We remain optimistic about the new da Vinci Xi surgical system, which has received both the FDA approval and CE Mark. The upgraded

Strength Seen in Opko Health (OPK): Stock Rises 8.3% - Tale of the Tape
Opko Health, Inc. ( OPK ) was a big mover last session with shares rising over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This

Varian (VAR) Now a Strong Sell on Challenging Q1 Outlook - Analyst Blog
On Dec 11, 2014, Zacks Investment Research downgraded Varian Medical Systems ( VAR ) to a Zacks Rank #5 (Strong Sell).Why the Downgrade? The downgrade primarily reflects Varian's challenging near term outlook. Both Oncology and Imaging segments of the

Novadaq Technologies Inc. (NVDQ) in Focus: Stock Soars 17.1% - Tale of the Tape
Novadaq Technologies Inc. ( NVDQ ) was a big mover last session, as the company saw its shares rise by over 17% on the day. The move came on solid volume too with far more shares changing hands than

Cyberonics Posts Positive Epilepsy Device Data, Shares Up - Analyst Blog
Shares of TX based medical device manufacturer Cyberonics Inc. ( CYBX ) rallied 2.5% to eventually close at $55.25 yesterday, following the company's recently reported positive results from two multi site clinical trials on AspireSR generator the new sixth

Hologic (HOLX) Turns Around: Should You Invest Now? - Analyst Blog
On Dec 4, 2014, we issued an updated research report on Hologic Inc. ( HOLX ). This notable provider of premium diagnostic products, medical imaging systems and surgical products reported better than expected fourth quarter and fiscal 2014 financial

Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog
California based molecular diagnostics company Cepheid ( CPHD ) has received the U.S. Food & Drug Administration (FDA) clearance for selling its qualitative in vitro diagnostic test Xpert Norovirus in the U.S. market. The Xpert Norovirus test is designed

Edwards Lifesciences Strong on Robust Q3, Raised Outlook - Analyst Blog
On Nov 26, we issued an updated research report on medical technology major Edwards Lifesciences Corp. ( EW ). This notable provider of heart valve products and hemodynamic monitoring system reported better than expected third quarter 2014 financial results